Along with overexpression, CDK4/6 upregulation is a common occurrence in various malignancies (melanoma, leukemia, lymphoma, glioma, sarcoma, etc.)with distinct tissue selectivity for CDK4/6. This evidence concerns the gene CDK4 and sarcoma.